| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |